recombinant human plasminogen是什么意思

网络释义

用法例句

Study on expression, renaturation and purification of reteplase;

重组人组织型纤溶酶原激活剂改构体的表达、复性与分离纯化

Research on reteplase renaturation in vitro;

重组人组织型纤溶酶原激活剂改构体复性研究

Thrombolysis Effects of Recombinant Human Tissue Type Plasminogen Activator(Reteplase) on Coronary Artery Thrombosis in Dogs;

重组人组织型纤溶酶原激活剂缺失变体对犬冠状动脉血栓的溶栓作用

Thrombolyti c effect and influence of reteplase on platelet aggregation and the concentration of free calcium in cytoplasma;

重组人组织型纤溶酶原激活剂缺失变体的溶栓作用及对血小板聚集和胞浆游离钙离子浓度的影响

Effects of reteplase on fibrinolytic and coagulation systems in rabbits;

重组人组织型纤溶酶原激活剂缺失变体对家兔纤溶和凝血系统活性的影响

Methods The target protein (rPAm) gene was amplified from plasmid pLFrGGI by PCR and subcloned to the yeast expression vector pPMEX9K.

目的在毕赤酵母中表达重组人组织型纤溶酶原激活剂衍生物(rPAm),并检测rPAm的活性。

recombinant human plasminogen

重组体人纤溶酶原激活质

Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test

重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较

Study on Recombinant Nonglycosylated Urokinase-type Plasminogen Activator;

重组非糖基化尿激酶型纤溶酶原激活剂的研究

DETERMINATION OF THE PLASMINOGEN ACTIVATOR IN THE TONSIL OF CHRONIC TONSILLITIS

慢性扁桃体炎组织中的纤溶酶原激活剂测定

Evaluation of the therapeutic effect of thrombolytic therapy with rt-PA and nursing intervention in patients with acute myocardial infarction

急性心肌梗死重组组织型纤溶酶原激活剂溶栓治疗的观察及护理

Therapeutic effect observation of thrombolysis with rt-PA intravenous in recurrent cerebral infarction

重组组织型纤溶酶原激活剂对再发性脑梗死静脉溶栓治疗评价

Therapeutic Effect of Ultra Earlier Thrombolysis of Recombinant Tissue Plasminogen Activator in Acute Cerebral Infarction

重组组织型纤溶酶原激活剂超早期溶栓治疗急性脑梗死的疗效

Thrombolytic therapy with intravenous recombinant tissue plasminogen activator for acute cerebral infarction

重组组织型纤溶酶原激活剂静脉溶栓治疗急性脑梗死19例

Intravenous thrombolytic therapy with recombinant-tissue plasminogen activator for super early stage of cerebral infarction

重组组织型纤溶酶原激活物rt-PA静脉溶栓治疗超早期脑梗死

Expressions of Survivin and uPA in human cerebral gliomas

脑胶质瘤组织中Survivin和尿激酶型纤溶酶原激活物蛋白的表达

Clinical Study of the Expression of Tissue Factor and Urokinase Plasminogen Activator Receptor in Breast Cancer

组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达

Experimental Study on Posterior Vitreous Detachment Induced by Tissue Plasminogen Activator Combined with Hyaluronidase in Rabbits;

组织纤维蛋白溶酶原激活剂联合透明质酸酶致玻璃体后脱离的动物实验研究

The Recombinant Human Tissue-type Plasminogen Activator in the Treatment of Deep Venous Thrombosis of the Lower Extremities

重组组织型纤溶酶原激活剂治疗下肢深静脉血栓形成的临床应用

Experimental study on prevention of the peritoneal adhesion by recombinant tissue-type plasminogen activator on rats

重组组织型纤溶酶原激活剂预防大鼠腹腔粘连的实验研究

Therapeutic effect evaluation of recombinant tissue plasminogen activator in hyper acute cerebral infarction

重组组织型纤溶酶原激活剂治疗急性脑梗死的疗效评价

Comparative study on intravenous rt-PA and uroninase thrombolytic strategy for acute myocardial infarction

重组组织型纤溶酶原激活剂与尿激酶静脉内溶栓治疗急性心肌梗死的比较研究

Establishment of Transgenic Goats for Human Tissue-type Plasminogen Activator with Sperm Mediated Gene Transfer Method;

利用精子载体方法研制人组织型纤溶酶原激活剂突变体转基因羊乳腺生物反应器

Construction of Bacterial Artificial Chromosome Vectors Containing Human Tissue-type Plasminogen Activator Mutant Gene Specially Expressed in Mammary Gland with Red Recombination System;

利用Red系统构建人组织型纤溶酶原激活剂突变体BAC乳腺特异表达载体